Articles On Cann Group (ASX:CAN)

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

US States who allow recreational cannabis see less codeine demand WA GP wants Snoop Dogg to drop into parliament to chat cannabis reform Neurotech nabs pre-submission meeting with US FDA for CBD drug NTI164   A Cornell University study ha...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Germany: Next target for cannabis producers, huge market and could be live in 12 months Other Euro states about to legislate on industry in next few years Stockhead reached out to Little Green Pharma’s founder and CEO, Fleta Solomon   Fol...

Cann Group (CAN) appoints Peter Koetsier as its new CEO following an extensive search process Mr Koetsier will replace Peter Crock, who announced that he would be stepping down as CEO of the company last October The incoming CEO has...

Less than two months after announcing that Peter Crook would be stepping down as top boss, medicinal cannabis company Cann Group (ASX: CAN) has appointed Peter Koetsier as its new CEO from 16 January. The incoming executive held senior pos...

The ASX will open marginally lower on Tuesday Overnight, Wall Street was mixed but turned negative after comments from US Fed policymakers Oil prices rose another 1pc   Aussie shares will open marginally lower this morning, and at 8am AED...

Penington Institute says pot-related law enforcement costs us $1.7 billion a year   Local cannabis is missing out on international and domestic market opportunities Aussie medicinal cannabis revenue was around $230 million in 2021   Decri...

ASX Health sector has ended its upward trend falling 0.7% in the past five days in line with broader markets As the end of 2022 approaches several ASX health stocks announce capital raising results to secure funding Healius announces sal...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

Two more US states join the 19 that already allow legal recreational cannabis use ECS Botanics’ Victorian medical cannabis facility is safe from flooding in the state, so far Cann looks to commercialise its Satipharm CBD capsules for over-...

Germany looks to legalise recreational cannabis and US and Canadian companies are paying attention  Neurotech reports success with its cannabis-based drug for paediatric autism symptoms  ECS Botanics has sold its Tasmanian business and a...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.3% to 6,799.7 points. Four ASX shares that have failed to follow the market higher today are...

Peter Crock resigns as CEO of Cann Group (CAN) but will remain in the position until a new CEO has been appointedSince joining Cann in May 2016, Mr Crock led the company through its IPO and helped raise $13.5 million to support it A search...

The man who led medicinal cannabis company Cann Group (ASX: CAN) through its 2017 initial public offering (IPO) is set to step down after six years in the role, leaving behind a legacy of three production sites including a flagship $115 mil...

ASX cannabis shares have leapt back onto investor radars and are likely to grab more media headlines in the weeks ahead. While all three are deep in the red today amid wider selling action that sees the All Ordinaries Index (ASX: XAO) down...

ShareCafeASX moves lower amidst fears of another Fed rate hike: Aus shares 0.6% down at noon by Peter Milios   At noon, S&P/ASX 200 is 0.61 per cent or 41.90 points lower at 6775.60, following a tumultuous day in the US markets, as the...

ShareCafeStocks of the Hour: TBN, KGD                    Cannabis stocks were the highlight overnight as President Joe Biden pardoned all prior federal offences of simple marijuana possession. This has flowed through to medicinal cann...

Blood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks are in the blood clot space Top performing ASX healthcare stocks in the past month Blood clots were top of biotech news this week after re...

Cambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown cannabis in the ACT Incannex joins the big leagues S&P/ASX300 index   It turns out that the lazy stoner stereotype is actually a myth,...

Researchers say data shows transition from illicit to legal use of cannabis Medicinal users are at 37%, compared to 2.5% in 2018 Regulations, quality control and costs still barriers for legal week users   New research from the University...

ASX cannabis shares have been mixed performers on the market in the year to date, but are there better days ahead? Cannabis shares on the ASX include Cronos Australia Ltd (ASX: CAU), Incannex Healthcare Ltd (ASX: IHL), Emyria Ltd (ASX: E...

Ice-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm led a seed funding round for TSUMo Snacks Incannex ramps up development and manufacturing of IHL-216A drug New Jersey has given Ice-T the gre...

Mysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS nabs $2m commercial loan facility to invest in new capacity ICYMI a mysterious pink glow above Mildura sent residents into a bit of a frenzy...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Retail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufacturing practice (GMP) licence for its Mildura facility Bod plans to launch a low dose CBD schedule 3 product into the Australian market  ...

The ASX 200 closes lower Small caps lose circa 18% in June Control Bionics jumps 60%   It’s been an exhausting June for Aussie small caps. Down again on Thursday as the energy sector wilts, the S&P Emerging Companies (XEC) has lost 18...

Cann Group (CAN) receives a good manufacturing practice (GMP) licence for its Mildura facility in Victoria from the Therapeutic Goods Administration (TGA) This licence allows Cann to produce active pharmaceutical ingredients and hard capsu...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another decline. At the time of writing, the benchmark index is down 0.9% to 6,639.3 points. Four ASX shares that are not letting that hold them back are list...

The Cann Group Ltd (ASX: CAN) share price is rocketing on Thursday. This comes after the cannabis company announced a positive update regarding its Mildura facility. At the time of writing, Cann shares are fetching at 27.5 cents, up 19.57%...

Cann Group’s Mildura facility has been granted GMP licence Paradigm receives patent application acceptance by IP Australia Starpharma to relaunch VIRALZEE with LloydsPharmacy in the UK Cannabis company Cann Group (ASX:CAN) rose 17% this m...

A Thai university says adding cannabis to chicken feed has positive results on meat and egg quality Aussie cannabis campaigner now a Member of the Order of Australia MGC Pharma’s CBD treatment proves effective against brain tumors   Chian...

Boston Beer Co launches cannabis iced tea in Canada University of Sydney says using CBD and driving is no worries Emyria reports positive Phase 1 study results for ultra-pure CBD capsule The Boston Beer Co is launching a line of cannabis-...

Fresh from receiving permission in March to start cultivating medicinal cannabis at its northwest Victorian facility in Mildura, Cann Group (ASX: CAN) has announced it has commenced harvesting the first crop at its new flagship site. The M...

Actor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wellness retreat in Byron Bay Incannex wants to buy out APIRx   It’s not surprising that Woody Harrelson loves weed – the actor was actually...

Actor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Franchise Global Health has established the first legal seedbank in Denmark Botanix nabs FDA Qualified Infection Disease Product designation for...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The TGA down-scheduled low dose CBD in February for over-the-counter sales without a prescription Currently no CBD drugs have been approved for sale in Australia Cann Group reckons S3 registration could open the door to millions of patient...

The ASX will head into the Anzac day long weekend on a slightly sour note following a Friday selloff. For the microcap Emerging Companies index, it was a ~1.5% fall on the day — but that didn’t stop another triple-digit percentage return, t...

US Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax holiday Medlab clinical makes moves in the Northern Hemisphere with manufacturing deal Wednesday was 4/20 day – while it’s more of an unoff...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

It’s been an emotional ride for fans of the ASX200 (XJO) which, alongside the Emerging Companies (XEC) index, (down 0.6%) gave up its early gains in a topsy-turvy Monday session. Just after the close, the XJO was weepingly flat – well, up 0...

The ASX lost ground on Thursday. Weak leads out of Wall Street, more threats of Western-led sanctions v. Russia and a more hawkish tone out of the Federal Reserve left the benchmark 0.6% down with a half hour before the closing bell. Follow...

Cann will market its CBD capsules in Australia 4DMedical’s XV LVAS software is being trialed in a hospital in California Polynovo’s record March quarter Cann to market CBD capsules in Australia Cannabis company Cann Group (ASX:CAN) has en...

In what could be a major coup for Cann Group (ASX: CAN), GlaxoSmithKline (GSK) Consumer Healthcare has entered into an evaluation agreement with the Australian medicinal cannabis company to explore the commercialisation of its CBD capsules....

Highlights ASX 200 closed 0.1% lower and ended the week 1.2% stronger to post the third consecutive week of increases. While tech and consumer discretionary sectors came under pressure, materials was the best performing sector today....

Cann Group (CAN) gets the tick of approval from the UK Foods Standards Agency (FSA) for its Satipharm range of CBD products The company said this is a “major opportunity” as it allows its CBD products to be sold in the UK The capsules are...

Cann Group gets the OK in the UK for its CBD food supplements Starpharma to relaunch VIRALEZE in the UK Creso expands to LATAM Cann Group gets OK in the UK Cannabis company Cann Group (ASX:CAN) has received the green light from the UK FSA...